Capital Expenditures for Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current capital expenditures (TTM) is $1.86B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingCapital ExpendituresSwitch metric
Latest period
$1.86B
YoY change
+69.5%
5Y CAGR
+25.0%
Peak year (2025)
$1.86B
Cumulative capital expenditures
$24.67B
CapEx history chart for Amgen (AMGN) from 1988 to 2025
CapEx history table for Amgen (AMGN) from 1988 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $1.86B | +69.5% | ||
| 2024 | $1.10B | -1.4% | ||
| 2023 | $1.11B | +18.8% | ||
| 2022 | $936.00M | +6.4% | ||
| 2021 | $880.00M | +44.7% | ||
| 2020 | $608.00M | -1.6% | ||
| 2019 | $618.00M | -16.3% | ||
| 2018 | $738.00M | +11.1% | ||
| 2017 | $664.00M | -20.7% | ||
| 2016 | $837.00M | +29.0% | ||
| 2015 | $649.00M | -35.3% | ||
| 2014 | $1.00B | +44.7% | ||
| 2013 | $693.00M | +0.6% | ||
| 2012 | $689.00M | +21.5% | ||
| 2011 | $567.00M | -2.2% | ||
| 2010 | $580.00M | +9.4% | ||
| 2009 | $530.00M | -21.1% | ||
| 2008 | $672.00M | -47.0% | ||
| 2007 | $1.27B | +4.0% | ||
| 2006 | $1.22B | +40.5% | ||
| 2005 | $867.00M | -35.1% | ||
| 2004 | $1.34B | -1.5% | ||
| 2003 | $1.36B | +106.0% | ||
| 2002 | $658.50M | +49.0% | ||
| 2001 | $441.80M | +0.9% | ||
| 2000 | $437.70M | +43.9% | ||
| 1999 | $304.20M | -25.4% | ||
| 1998 | $407.80M | +5.2% | ||
| 1997 | $387.80M | +45.3% | ||
| 1996 | $266.90M | +64.0% | ||
| 1995 | $162.70M | +24.4% | ||
| 1994 | $130.80M | -37.7% | ||
| 1993 | $209.90M | -4.5% | ||
| 1992 | $219.80M | +87.4% | ||
| 1991 | $117.30M | +80.7% | ||
| 1990 | $64.90M | +47.2% | ||
| 1989 | $44.10M | +2.1% | ||
| 1988 | $43.20M | — |
CapEx values are taken from Amgen's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Amgen (AMGN) capital expenditures totalled $1.86B – surged 69.5% year-over-year.
Through 2020–2025 (5 years), Amgen capital expenditures delivered a +25.0% annualised rate; with the latest reading among the more recent periods of the dataset.
2025 marks the peak capital expenditures at $1.86B, with the historical low of $43.20M recorded in 1988.
Amgen (AMGN) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Amgen Capital Expenditures by Year
Amgen Capital Expenditures 2025: $1.86B
Amgen capital expenditures in 2025 was $1.86B, surged 69.5% from 2024. This figure represents the highest annual value in the available history.
Amgen Capital Expenditures 2024: $1.10B
Amgen capital expenditures in 2024 was $1.10B, edged down 1.4% below 2023.
Amgen Capital Expenditures 2023: $1.11B
Amgen capital expenditures in 2023 was $1.11B, grew 18.8% from 2022.
Amgen Capital Expenditures 2022: $936.00M
Amgen capital expenditures in 2022 was $936.00M, grew 6.4% from 2021.
Amgen Capital Expenditures 2021: $880.00M
Amgen capital expenditures in 2021 was $880.00M.
See more financial history for Amgen (AMGN).
Sector peers — CapEx
Companies in the same sector as Amgen, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $1.52B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Amgen's capital expenditures?
- Latest reported capital expenditures for Amgen (AMGN) is $1.86B (period ending December 31, 2025).
How has Amgen capital expenditures changed year-over-year?
- Amgen (AMGN) capital expenditures changed +69.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen capital expenditures?
- Amgen (AMGN) capital expenditures compound annual growth rate is +25.0% over the most recent 5 years available.
When did Amgen capital expenditures hit its highest annual value?
- Amgen capital expenditures reached its highest annual value of $1.86B in 2025.
What was Amgen capital expenditures in 2024?
- Amgen (AMGN) capital expenditures in 2024 was $1.10B.
What was Amgen capital expenditures in 2025?
- Amgen (AMGN) capital expenditures in 2025 was $1.86B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.